Nanobiotix SA to Participate in Major Investor Conferences

Nanobiotix SA will participate in several investor conferences the week of November 10, 2025. Company management, including Chief Executive Officer Laurent Levy and Chief Financial & Business Officer Bart van Rhijn, will present at the UBS Global Healthcare Conference on November 10, the Guggenheim Annual Healthcare Innovation Conference on November 10, and the Stifel Healthcare Conference on November 13. The company, a late-clinical stage biotechnology firm focused on nanotherapeutic approaches for cancer and other diseases, will join fireside chats at these events. Recordings will be available on the company’s website. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nanobiotix SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9567606-en) on November 03, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)